Jump to navigation

Vol 65 No 9

Published 25th April 2024


Kenya

After the pandemic panic, Big Pharma exits Africa

Moderna's mothballing of a $200m vaccine plant has prompted a backlash from politicians and health professionals

When United States' pharmaceutical giant Moderna halted plans for a US$200 million vaccine factory near Nairobi it dealt a double-blow: to Kenya's ambitions as a healthcare manufacturing hub and Africa's hopes of vaccine self-sufficiency to manage future pandemics.

End of preview - This article contains approximately 776 words.

End of preview

Subscribers: Log in now to read the complete article.

Account Holders: Log in now and use your Account Credit to buy this article. No Credit? Top up your Account now.


If you are logged in, but still cannot access the full text of this article, email customer services or telephone us on +44(0)1638 743633.